PMCB logo

PharmaCyte Biotech (PMCB) Accounts Payable

Annual Accounts Payable

$389.40 K
+$261.10 K+203.51%

April 30, 2024

Summary

Performance

1-Year Change

+203.51%

3-Year Change

+126%

5-Year Change

+219.44%

15-Year Change

+6.51%

PMCB Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

5.99%
PMCB annual accounts payable is higher than 5.99% of companies in Healthcare sector

High & Low

All-time High

$730.10 K
PMCB annual accounts payable is currently -46.66% below its historical high of $730.10 thousand

3-Year Low

$128.30 K
PMCB annual accounts payable is currently +203.51% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Apr 30, 2024
PMCB previous annual earnings announcement was published on Apr 30, 2024

Next Annual Earnings Report Date

N/A
PMCB next annual earnings announcement has not yet been scheduled

OtherPMCBbalance sheetmetrics:

Annual Accounts Receivable

-
PMCB annual accounts receivable value is unknown

Annual Total Liabilities

$20.39 M
PMCB annual total liabilities is $20.39 million

Annual Total Assets

$59.90 M
PMCB annual total assets is $59.90 million

Annual Current Assets

$50.44 M
PMCB annual total current assets is $50.44 million

Quarterly Accounts Payable

$348.60 K
-$205.40 K-37.08%

October 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

-21.82%

5-Year Change

-21.82%

PMCB Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

5.33%
PMCB quarterly accounts payable is higher than 5.33% of companies in Healthcare sector

High & Low

All-time High

$861.30 K
PMCB quarterly accounts payable is currently -59.53% below its historical high of $861.30 thousand

3-Year Low

$92.90 K
PMCB quarterly accounts payable is currently +275.24% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Oct 31, 2024
PMCB previous earnings announcement was published on Oct 31, 2024

Next Quarterly Earnings Report Date

Mar 18, 2025
PMCB next earnings announcement is scheduled for Mar 18, 2025

OtherPMCBbalance sheetmetrics:

Quarterly Accounts Receivable

-
PMCB quarterly accounts receivable value is unknown

Quarterly Total Liabilities

$11.65 M
PMCB quarterly total liabilities is $11.65 million

Quarterly Total Assets

$55.10 M
PMCB quarterly total assets is $55.10 million

Quarterly Current Assets

$21.33 M
PMCB quarterly total current assets is $21.33 million

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

PMCB Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+203.5%0.0%
3 y3 years+126.0%-21.8%
5 y5 years+219.4%-21.8%

PMCB Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+203.5%-59.5%+275.2%
5 y5-yearat high+219.4%-59.5%+340.1%
alltimeall time-46.7%>+9999.0%-59.5%>+9999.0%

PharmaCyte Biotech Accounts Payable History

DateAnnualQuarterly
Oct 2024
-
$348.60 K(-37.1%)
Jul 2024
-
$554.00 K(+42.3%)
Apr 2024
$389.40 K(+203.5%)
$389.40 K(-19.6%)
Jan 2024
-
$484.20 K(+283.7%)
Oct 2023
-
$126.20 K(-82.4%)
Jul 2023
-
$718.10 K(+459.7%)
Apr 2023
$128.30 K(-37.5%)
$128.30 K(-71.2%)
Jan 2023
-
$445.90 K(-48.2%)
Oct 2022
-
$861.30 K(+54.1%)
Jul 2022
-
$559.00 K(+172.2%)
Apr 2022
$205.40 K(+19.2%)
$205.40 K(+121.1%)
Jan 2022
-
$92.90 K(-40.8%)
Oct 2021
-
$157.00 K(-60.2%)
Jul 2021
-
$394.80 K(+129.1%)
Apr 2021
$172.30 K(-7.3%)
$172.30 K(+117.6%)
Jan 2021
-
$79.20 K(-1.1%)
Oct 2020
-
$80.10 K(-79.2%)
Jul 2020
-
$384.80 K(+107.1%)
Apr 2020
$185.80 K(+52.4%)
$185.80 K(-45.4%)
Jan 2020
-
$340.50 K(+106.9%)
Oct 2019
-
$164.60 K(+143.9%)
Jul 2019
-
$67.50 K(-44.6%)
Apr 2019
$121.90 K(-65.4%)
$121.90 K(-8.8%)
Jan 2019
-
$133.70 K(-61.6%)
Oct 2018
-
$348.60 K(-39.4%)
Jul 2018
-
$575.00 K(+63.1%)
Apr 2018
$352.60 K(-3.6%)
$352.60 K(+15.4%)
Jan 2018
-
$305.60 K(-1.7%)
Oct 2017
-
$310.80 K(-50.5%)
Jul 2017
-
$628.20 K(+71.8%)
Apr 2017
$365.60 K(+8.8%)
$365.60 K(-16.0%)
Jan 2017
-
$435.00 K(+44.6%)
Oct 2016
-
$300.90 K(-3.4%)
Jul 2016
-
$311.60 K(-7.3%)
Apr 2016
$336.00 K(-32.4%)
$336.00 K(-51.8%)
Jan 2016
-
$697.30 K(+63.2%)
Oct 2015
-
$427.20 K(+3.4%)
Jul 2015
-
$413.10 K(-16.8%)
Apr 2015
$496.70 K(+164.2%)
$496.70 K(+32.2%)
Jan 2015
-
$375.80 K(+38.1%)
Oct 2014
-
$272.10 K(+33.1%)
Jul 2014
-
$204.40 K(+8.7%)
DateAnnualQuarterly
Apr 2014
$188.00 K(-46.6%)
$188.00 K(+12.1%)
Jan 2014
-
$167.70 K(-41.3%)
Oct 2013
-
$285.70 K(-3.3%)
Jul 2013
-
$295.60 K(-16.0%)
Apr 2013
$352.00 K(-51.8%)
$352.00 K(-32.0%)
Jan 2013
-
$517.40 K(+11.6%)
Oct 2012
-
$463.70 K(+9.3%)
Jul 2012
-
$424.20 K(-41.9%)
Apr 2012
$730.10 K(+3.4%)
$730.10 K(+27.6%)
Jan 2012
-
$572.30 K(-18.6%)
Oct 2011
-
$703.00 K(+1.5%)
Jul 2011
-
$692.60 K(-1.9%)
Apr 2011
$705.80 K(+4.6%)
$705.80 K(-5.7%)
Jan 2011
-
$748.70 K(+1.2%)
Oct 2010
-
$739.90 K(+1.9%)
Jul 2010
-
$726.10 K(+7.6%)
Apr 2010
$674.80 K(+221.5%)
$674.80 K(+17.1%)
Jan 2010
-
$576.50 K(+27.2%)
Oct 2009
-
$453.40 K(+46.2%)
Jul 2009
-
$310.20 K(+47.8%)
Apr 2009
$209.90 K(+46.1%)
$209.90 K(+267.6%)
Jan 2009
-
$57.10 K(+12.0%)
Oct 2008
-
$51.00 K(+27.2%)
Jul 2008
-
$40.10 K(-72.1%)
Apr 2008
$143.70 K(+45.0%)
$143.70 K(+183.4%)
Jan 2008
-
$50.70 K(-31.5%)
Oct 2007
-
$74.00 K(+8.0%)
Jul 2007
-
$68.50 K(-30.9%)
Apr 2007
$99.10 K(+30.2%)
$99.10 K(-87.5%)
Jan 2007
-
$794.70 K(+634.5%)
Oct 2006
-
$108.20 K(+42.2%)
Jul 2006
-
$76.10 K(0.0%)
Apr 2006
$76.10 K(-70.5%)
$76.10 K(-68.0%)
Jan 2006
-
$237.80 K(0.0%)
Oct 2005
-
$237.80 K(+5.8%)
Jul 2005
-
$224.70 K(-12.8%)
Apr 2005
$257.80 K(>+9900.0%)
$257.80 K(+2309.3%)
Oct 2004
-
$10.70 K(+109.8%)
Jul 2004
-
$5100.00(+1600.0%)
Apr 2004
$300.00(-88.0%)
$300.00(-94.2%)
Jan 2004
-
$5200.00(+108.0%)
Apr 2003
$2500.00
$2500.00

FAQ

  • What is PharmaCyte Biotech annual accounts payable?
  • What is the all time high annual accounts payable for PharmaCyte Biotech?
  • What is PharmaCyte Biotech annual accounts payable year-on-year change?
  • What is PharmaCyte Biotech quarterly accounts payable?
  • What is the all time high quarterly accounts payable for PharmaCyte Biotech?
  • What is PharmaCyte Biotech quarterly accounts payable year-on-year change?

What is PharmaCyte Biotech annual accounts payable?

The current annual accounts payable of PMCB is $389.40 K

What is the all time high annual accounts payable for PharmaCyte Biotech?

PharmaCyte Biotech all-time high annual accounts payable is $730.10 K

What is PharmaCyte Biotech annual accounts payable year-on-year change?

Over the past year, PMCB annual accounts payable has changed by +$261.10 K (+203.51%)

What is PharmaCyte Biotech quarterly accounts payable?

The current quarterly accounts payable of PMCB is $348.60 K

What is the all time high quarterly accounts payable for PharmaCyte Biotech?

PharmaCyte Biotech all-time high quarterly accounts payable is $861.30 K

What is PharmaCyte Biotech quarterly accounts payable year-on-year change?

Over the past year, PMCB quarterly accounts payable has changed by $0.00 (0.00%)